Drug Utilization Review Board is responsible for making recommendations in four areas: application of standards (as described in Section 8.838); retrospective drug utilization review (DUR); ongoing intervention with pharmacists and physicians concerning therapy problems identified in the course of the DUR program; and recommendations regarding prior authorization criteria.
